Stockreport

Protara Therapeutics Announces Oversubscribed $45 Million Private Placement Financing

Protara Therapeutics, Inc.  (TARA) 
PDF NEW YORK, April 05, 2024 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment [Read more]